Cargando…

Nuclear Structure and its Modifications in Tumours

Detalles Bibliográficos
Autor principal:	Ludford, R. J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1954
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2007931/ https://www.ncbi.nlm.nih.gov/pubmed/13172388

Ejemplares similares

Factors Determining the Action of Colchicine on Tumour Growth
por: Ludford, R. J.
Publicado: (1948)

Cytological Results of Growing Tissues Under an Oil Film
por: Ludford, R. J.
Publicado: (1952)

In vivo 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modification.
por: Bremner, J. C., et al.
Publicado: (1991)

Nuclear modification of transverse-longitudinal structure function ratio
por: Ericson, M, et al.
Publicado: (2002)

Modification of the 31P magnetic resonance spectra of a rat tumour using vasodilators and its relationship to hypotension.
por: Tozer, G. M., et al.
Publicado: (1990)

Modification of jet structure in nuclear collisions: theory overview (and pp perspective)
por: Salam, Gavin P
Publicado: (2019)

Jet Modifications in Nuclear Collisions
por: Sickles, Anne Marie
Publicado: (2018)

Nuclear Modification of Dijet at EIC
por: Zhang, Yuanyuan
Publicado: (2020)

Modification of tumour radiation response in vivo by the benzamide analogue pyrazinamide.
por: Chaplin, D. J., et al.
Publicado: (1990)

Effect of radiation on nuclear phosphorylation in human malignant tumours.
por: Fahmy, A. R., et al.
Publicado: (1965)

Nuclear medicine imaging and therapy of neuroendocrine tumours
por: Gotthardt, Martin, et al.
Publicado: (2006)

Enhanced tumour cell nuclear targeting in a tumour progression model
por: Nastasie, Michael S, et al.
Publicado: (2015)

Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
por: Twentyman, P. R.
Publicado: (1981)

The nuclear matter modification at intermediate energies
por: Penev, V, et al.
Publicado: (2002)

Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
por: Rojas, A., et al.
Publicado: (1983)

Chitosan and Its Structural Modifications for siRNA Delivery
por: Al-Absi, Mona Y., et al.
Publicado: (2023)

Modification by WR 2721 of the response to chemotherapy of tumours and normal tissues in the mouse.
por: Twentyman, P. R.
Publicado: (1983)

Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade
por: Altura, R A, et al.
Publicado: (2003)

Chromatin Dynamics in Interphase Nuclei and Its Implications for Nuclear Structure
por: Abney, James R., et al.
Publicado: (1997)

Molecular Characterization of the SUMO-1 Modification of RanGAP1 and Its Role in Nuclear Envelope Association
por: Mahajan, Rohit, et al.
Publicado: (1998)

Regulation of epigenetic modifications in the head and neck tumour microenvironment
por: Liu, Huimin, et al.
Publicado: (2022)

Observation of $\rho/\omega$ meson modification in nuclear matter
por: Ozawa, K, et al.
Publicado: (2000)

THE NUCLEAR ENVELOPE : ITS STRUCTURE AND RELATION TO CYTOPLASMIC MEMBRANES
por: Watson, Michael L.
Publicado: (1955)

Strangeness production and nuclear modification at LHC energies
por: Busch, Oliver
Publicado: (2017)

Nuclear modification of jet and hadron spectra with CMS
por: Tonjes, Marguerite Belt
Publicado: (2015)

Nuclear modification of Y states in PbPb
por: CMS Collaboration
Publicado: (2015)

Nuclear modification factors from the CMS experiment
por: Lee, Yen-Jie
Publicado: (2011)

Modification by vasoactive drugs of tumour destruction by photodynamic therapy with haematoporphyrin derivative.
por: Cowled, P. A., et al.
Publicado: (1989)

Chemical modification and immunogenicity of membrane fractions from mouse tumour cells.
por: Staab, H. J., et al.
Publicado: (1978)

Germline Genetic Modification and Identity: the Mitochondrial and Nuclear Genomes
por: Scott, Rosamund, et al.
Publicado: (2017)

The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibody.
por: Pedley, R. B., et al.
Publicado: (1994)

A Review on Structure, Modifications and Structure-Activity Relation of Quercetin and Its Derivatives
por: Magar, Rubin Thapa, et al.
Publicado: (2020)

Structural Modifications of siRNA Improve Its Performance In Vivo
por: Chernikov, Ivan V., et al.
Publicado: (2023)

A Tumour Showing Mitotic Division within an Apparent Nuclear Membrane
por: Calcutt, G., et al.
Publicado: (1954)

Tumour nuclear oestrogen receptor beta 1 correlates inversely with parathyroid tumour weight
por: Haglund, Felix, et al.
Publicado: (2015)

Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression
por: Tuhkanen, Hanna, et al.
Publicado: (2009)

In vivo nuclear magnetic resonance spectroscopy of a transplanted brain tumour.
por: Koeze, T. H., et al.
Publicado: (1984)

Nuclear hBD-1 accumulation in malignant salivary gland tumours
por: Wenghoefer, M, et al.
Publicado: (2008)

Reversibly contractile nuclear matrix. Its isolation, structure, and composition
Publicado: (1977)

Secondary Phase Interaction at Interfaces of High-Strength Brazed Joints made using Liquid Phase Sintered Alumina Ceramics and Ag-Cu-Ti Braze Alloys
por: Kassam, T. A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d89nnsvg84o6u2e3smvrg9fevh